Quintiles has purchased CRO Novella Clinical. The deal will bring Novella’s oncology, medical device and diagnostic trials into the Quintiles portfolio, but Novella will operate as a stand-alone unit.
Forest and Almirall are delaying an experimental COPD drug submission to the FDA. The drug is a combination of two bronchodilators, and the companies said in a statement Thursday that in pre-NDA discussions with the FDA, that the regulator had questions about “resolving chemistry, manufacturing and control specifications.” The two-for-one drug combines aclidinum bromide, known by the brand name Tudorza, and formoterol fumarate.
Paula Watch: Paula Deen’s rebound may have begun. One day after a judge threw out racism claims against the former Food Network star, Savannahnow.com reports that the celebrity chef may have a cameo on her son’s show “Home for Dinner with Jamie Deen.” Savannahnow.com notes that it is unclear if the episode was filmed before Deen’s reputation began to plummet.
